Preclinical evaluation of a novel integrin-targeting non-RGD small molecular radioligand, Ga-67-/Y-90-FF58, for tumor imaging and radionuclide therapy

Fukunaga H.; Nagano A.; Oshikiri S.; Kajita M.; Kambara H.; Komatsu K.; Shinichiro S.; Hino A.; Kasahara H.

首页> 外文期刊>The Journal of Nuclear Medicine >Preclinical evaluation of a novel integrin-targeting non-RGD small molecular radioligand, Ga-67-/Y-90-FF58, for tumor imaging and radionuclide therapy

【24h】

Preclinical evaluation of a novel integrin-targeting non-RGD small molecular radioligand, Ga-67-/Y-90-FF58, for tumor imaging and radionuclide therapy

机译：新型靶向整合素的非RGD小分子放射性配体Ga-67- / Y-90-FF58的临床前评估，用于肿瘤成像和放射性核素治疗

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of Nuclear Medicine》 |2015年第2期|共1页
作者
Fukunaga H.; Nagano A.; Oshikiri S.; Kajita M.; Kambara H.; Komatsu K.; Shinichiro S.; Hino A.; Kasahara H.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. Preclinical evaluation of a novel integrin-targeting non-RGD small molecular radioligand, Ga-67-/Y-90-FF58, for tumor imaging and radionuclide therapy [J] . Fukunaga H., Nagano A., Oshikiri S., The Journal of Nuclear Medicine . 2015,第Suppla2期

机译：新型靶向整合素的非RGD小分子放射性配体Ga-67- / Y-90-FF58的临床前评估，用于肿瘤成像和放射性核素治疗
2. Performance of Lu-177-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics [J] . Thapa Pradeep, Ranade Rohit, Ostwal Vikas, Nuclear Medicine Communications . 2016,第10期

机译：基于Lu-177-DOTATATE的肽受体放射性核素治疗转移性胃肠内胰腺神经内分泌肿瘤的性能：与原发肿瘤部位，肿瘤增殖指数和双示踪成像特征相关的多参数反应评估
3. Preclinical evaluation of new radioligand of cholecystokinin/gastrin receptors in endocrine tumors xenograft nude mice [J] . Brillouet S, Caselles O, Dierickx LO, Nuclear Instruments & Methods in Physics Research. Section A, Accelerators, Spectrometers, Detectors and Associated Equipment . 2007,第1a2期

机译：内分泌肿瘤异种裸鼠中胆囊收缩素/胃泌素受体新放射性配体的临床前评价
4. Preclinical Optical Molecular Imaging of cancer with tumor-selective molecular probes [C] . Samuel Achilefu Yangtze River 2009 international conference on medical imaging physics amp; the 5th national annual meeting of medical imaging physics . 2009

机译：肿瘤选择性分子探针对癌症的临床前光学分子成像
5. Preclinical pharmacokinetic and pharmacodynamic evaluation of new anticancer agents for brain tumor chemotherapy. [D] . Nuthalapati, Silpa. 2012

机译：用于脑肿瘤化疗的新型抗癌药的临床前药代动力学和药效学评估。
6. Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors [O] . Anzhelika Vorobyeva, Olga Bragina, Mohamed Altai, 2018

机译：放射性碘和Tech标记的DARPin 9_29对恶性肿瘤中HER2表达的放射性核素分子成像的比较评估
7. Molecularly targeted imaging and radionuclide therapy of non-thyroidal tumors following viral and non-viral sodium iodide symporter (NIS) gene delivery [O] . Klutz Kathrin 2010

机译：病毒性和非病毒性碘化钠同向转运体（NIs）基因传递后非甲状腺肿瘤的分子靶向成像和放射性核素治疗

Preclinical evaluation of a novel integrin-targeting non-RGD small molecular radioligand, Ga-67-/Y-90-FF58, for tumor imaging and radionuclide therapy

著录项

相似文献

相关主题

期刊订阅